Anti-human Amyloid Beta (U.Zurich patent Anti-Amyloid Beta Biosimilar)

Artikelnummer: BSS-BIO0813SM-20MG
Artikelname: Anti-human Amyloid Beta (U.Zurich patent Anti-Amyloid Beta Biosimilar)
Artikelnummer: BSS-BIO0813SM-20MG
Hersteller Artikelnummer: BIO0813SM-20mg
Alternativnummer: BSS-BIO0813SM-20MG-20
Hersteller: Bioss
Kategorie: Antikörper
Applikation: ELISA, FA, FACS, In vivo
Molekulargewicht: 145.9 kDa
UniProt: https://www.uniprot.org/uniprotkb/P05067/entry
Expression System: CHO
Target-Kategorie: Amyloid Beta